Invention Grant
- Patent Title: 5-substituted benzimidazolium compounds
- Patent Title (中): 5-取代的苯并咪唑鎓化合物
-
Application No.: US14330017Application Date: 2014-07-14
-
Publication No.: US09073954B2Publication Date: 2015-07-07
- Inventor: Joerg Kley , Sara Frattini , Dieter Hamprecht , Armin Heckel
- Applicant: Joerg Kley , Sara Frattini , Dieter Hamprecht , Armin Heckel
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP13176490 20130715
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D403/14 ; C07D493/04 ; C07F9/6509 ; A61K31/675 ; A61K45/06 ; A61K31/497 ; A61K31/683 ; A61K31/5377

Abstract:
The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.
Public/Granted literature
- US20150018313A1 NOVEL 5-SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS Public/Granted day:2015-01-15
Information query